Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toluenesulfonamide (PTS) for Stage IV Driver Gene-Negative NSCLC
NCT06607796Phase 3Recruiting
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of para-toluenesulfonamide in non-small cell lung cancer (NSCLC). Started Mar 2024; status: recruiting.
02
Drugs
para-toluenesulfonamide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06607796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06607796.